by James DeFranco | Mar 1, 2023 | Uncategorized
Notice of Proposed Rule by DEA Regarding CSOS | by: Deneen Fumich, RPh | Article Posted: March 1, 2023 | On February 2, 2023, the Federal Register included the notice of proposed rulemaking by the DEA for the purpose to amend the regulations to conform to the...
by James DeFranco | Jan 30, 2023 | Uncategorized
What is the Big Deal about Quantitative Thresholds? | by: Deneen Fumich, RPh | Article Posted: January 30, 2023 | Since July 21, 2021, industry has been hearing, reading and discussing the 10-year court ordered agreement better known as the “Injunctive Relief” which 3...
by James DeFranco | Jan 30, 2023 | Uncategorized
Can Compounding Pharmacies Help With Drug Shortage? | by: Deneen Fumich, RPh | Article Posted: January 30, 2023 | As parents, grandparents and caregivers, we all can relate to the feeling of helplessness when our children become ill. But we all have had the relief of...
by James DeFranco | Jan 20, 2023 | Uncategorized
Guidance On Quantitative Thresholds | by: Deneen Fumich, RPh | Article Posted: January 20, 2023 | As the Pharmaceutical Supply Chain continues to digest the Injunctive Relief requirements for the Big 3 Wholesalers, questions have been posed by industry to both the...
by James DeFranco | Jan 4, 2023 | Uncategorized
Oklahoma Prescription Shipping Proposed Rules | by: Deneen Fumich, RPh | Article Posted: January 4, 2023 | Controlled Temperature of Prescription Drugs Shipped to Residents of Oklahoma Oklahoma submitted to the Governor and Legislatures proposed rule changes to Title...
